Published on in Vol 5, No 1 (2019): Jan-Mar

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/12405, first published .
Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey

Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey

Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey

Journals

  1. Mayer K, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Advances in Therapy 2020;37(5):1778 View
  2. Ojikutu B, Amutah-Onukagha N, Mahoney T, Tibbitt C, Dale S, Mayer K, Bogart L. HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States. AIDS and Behavior 2020;24(10):2927 View
  3. Ojikutu B, Mayer K. Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis. The Journal of Infectious Diseases 2020;222(9):1428 View
  4. Hillis A, Germain J, Hope V, McVeigh J, Van Hout M. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming. AIDS and Behavior 2020;24(11):3056 View
  5. Rolle C, Onwubiko U, Jo J, Sheth A, Kelley C, Holland D. PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA. AIDS and Behavior 2019;23(S3):296 View
  6. Annequin M, Villes V, Delabre R, Alain T, Morel S, Michels D, Schmidt A, Velter A, Rojas Castro D. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017). AIDS Care 2020;32(sup2):47 View
  7. Golub S, Meyers K, Enemchukwu C. Perspectives and Recommendations From Lesbian, Gay, Bisexual, Transgender, and Queer/Questioning Youth of Color Regarding Engagement in Biomedical HIV Prevention. Journal of Adolescent Health 2020;66(3):281 View
  8. Shrestha R, DiDomizio E, Kim R, Altice F, Wickersham J, Copenhaver M. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. Journal of Substance Abuse Treatment 2020;117:108058 View
  9. Sullivan P, Woodyatt C, Koski C, Pembleton E, McGuinness P, Taussig J, Ricca A, Luisi N, Mokotoff E, Benbow N, Castel A, Do A, Valdiserri R, Bradley H, Jaggi C, O'Farrell D, Filipowicz R, Siegler A, Curran J, Sanchez T. A Data Visualization and Dissemination Resource to Support HIV Prevention and Care at the Local Level: Analysis and Uses of the AIDSVu Public Data Resource. Journal of Medical Internet Research 2020;22(10):e23173 View
  10. Sullivan P, Satcher Johnson A, Pembleton E, Stephenson R, Justice A, Althoff K, Bradley H, Castel A, Oster A, Rosenberg E, Mayer K, Beyrer C. Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses. The Lancet 2021;397(10279):1095 View
  11. Kim B, Chaix B, Chen Y, Callander D, Regan S, Duncan D. Geographic Density and Uptake of Pre-exposure Prophylaxis (PrEP) Among Young Gay, Bisexual and Other Sexual Minority Men: A Global Positioning System (GPS) Study. AIDS and Behavior 2021;25(S2):155 View
  12. Weiss K, Karuchit S, Pattanasin S, Chitwarakorn A, Wimonsate W, Suksamosorn J, Visavakum P, Sukwicha W, Ungsedhapand C, Dunne E, Holtz T. Spatial characteristics of men who have sex with men and transgender women attending HIV voluntary counselling and testing in Bangkok, Thailand, 2005–2015. Geospatial Health 2020;15(1) View
  13. Gilbert K, Ransome Y, Dean L, DeCaille J, Kawachi I. Social Capital, Black Social Mobility, and Health Disparities. Annual Review of Public Health 2022;43(1):173 View
  14. Guure C, Afagbedzi S, Torpey K. Willingness to take and ever use of pre-exposure prophylaxis among female sex workers in Ghana. Medicine 2022;101(5):e28798 View
  15. Sharpe J, Sanchez T, Siegler A, Guest J, Sullivan P. Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas. The Journal of Rural Health 2022;38(4):948 View
  16. Irie W, Calabrese S, Patel R, Mayer K, Geng E, Marcus J. Preferences for HIV Preexposure Prophylaxis Products Among Black Women in the U.S.. AIDS and Behavior 2022;26(7):2212 View
  17. Bonacci R, Smith D, Ojikutu B. Toward Greater Pre-exposure Prophylaxis Equity: Increasing Provision and Uptake for Black and Hispanic/Latino Individuals in the U.S.. American Journal of Preventive Medicine 2021;61(5):S60 View
  18. Waryold J, Shihabuddin C, Masciola R. Barriers to Culturally Competent Human Immunodeficiency Virus Care Among the Black, Indigenous, and People of Color Community. The Journal for Nurse Practitioners 2022;18(1):54 View
  19. Shacham E, Scroggins S, Ellis M. Implementing Geospatial Science and Technology to Get to Zero New HIV Infections. Current HIV/AIDS Reports 2023;20(3):139 View
  20. Irie W, Mahone A, Nakka R, Ghebremichael M. Confidence in Ability to Communicate With Sexual Partners About PrEP Among Black Cisgender Women. AIDS Education and Prevention 2023;35(5):333 View
  21. Sophus A, Mitchell J, Barroso J, Sales J. Factors Associated with Planned Future Use of PrEP in the Next 3 Months and Likelihood to Use PrEP Among Black Cisgender HIV-negative Women in Texas. AIDS and Behavior 2024;28(1):72 View
  22. Abu-Ba’are G, Shamrock O, Apreku A, Agbemedu G, Zigah E, Ezechi O, Nelson L, Torpey K. Awareness and Willingness to use Condoms and Preexposure Prophylaxis among Gay, Bisexual, and Other Cisgendered Men who Have sex with men in Slum Communities in Ghana. BSGH-004. Journal of the International Association of Providers of AIDS Care (JIAPAC) 2023;22 View
  23. Luan H, Li G, Duncan D, Sullivan P, Ransome Y. Spatial accessibility of pre-exposure prophylaxis (PrEP): different measure choices and the implications for detecting shortage areas and examining its association with social determinants of health. Annals of Epidemiology 2023;86:72 View
  24. Scott R, Deyarmond M, Marwitz S, Huang J, Moriarty P, Visconti A, Beverley J, Elion R, Coleman M, Hull S. Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic. AIDS Patient Care and STDs 2023;37(9):447 View
  25. Harrington K, Chandra C, Alohan D, Cruz D, Young H, Siegler A, Crawford N. Examination of HIV Preexposure Prophylaxis Need, Availability, and Potential Pharmacy Integration in the Southeastern US. JAMA Network Open 2023;6(7):e2326028 View
  26. Irie W, Mahone A, Nakka R, Ghebremichael M. Factors Associated with Comfort Discussing PrEP with Healthcare Providers among Black Cisgender Women. Tropical Medicine and Infectious Disease 2023;8(9):436 View
  27. Hassani M, De Haro C, Flores L, Emish M, Kim S, Kelani Z, Ugarte D, Hightow-Weidman L, Castel A, Li X, Theall K, Young S. Exploring mobility data for enhancing HIV care engagement in Black/African American and Hispanic/Latinx individuals: a longitudinal observational study protocol. BMJ Open 2023;13(12):e079900 View
  28. Irie W, Calabrese S, Mayer K, Geng E, Blackstock O, Marcus J. Social and structural factors associated with interest in HIV preexposure prophylaxis among Black women in the United States. AIDS Care 2024;36(5):672 View
  29. Dawit R, Goedel W, Reid S, Doshi J, Nunn A, Chan P, Dean L. Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties. AIDS 2024;38(4):557 View
  30. Seyedroudbari S, Ghadimi F, Grady G, Uzosike O, Nkwihoreze H, Jemmott J, Momplaisir F. Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review. AIDS and Behavior 2024;28(9):3001 View
  31. Shi F, Mi T, Li X, Ning H, Li Z, Yang X. Structural Racism and HIV Pre-exposure Prophylaxis Use in the Nationwide US: A County-Level Analysis. Journal of Racial and Ethnic Health Disparities 2024 View
  32. Traylor D, Enriquez M, Thompson-Robinson M, Yu M, Bloom T, Bullock L. Barriers and Facilitators That Influence HIV Pre-exposure Prophylaxis (PrEP)-Prescribing Behaviors Among Primary Care Providers in the Southern United States. Cureus 2024 View
  33. Sims Haynes A, Markham C, Schick V, Suchting R, Parthasarathy N, Choudhury S, Hill M. A Systematic Review and Narrative Synthesis of Factors Affecting Pre-exposure Prophylaxis Willingness Among Black Women for HIV Prevention. AIDS and Behavior 2024 View
  34. Yuh T, Lalley-Chareczko L, Zanders D, Shaw H, Spencer T, Serafin D, Koenig H, Momplaisir F. Acceptability and Feasibility of Implementing a Home-Based HIV Pre-Exposure Prophylaxis Program in an Urban Clinic. AIDS Patient Care and STDs 2024;38(12):566 View
  35. Sullivan P, Mera-Giler R, Bush S, Shvachko V, Sarkodie E, O'Farrell D, Dubose S, Magnuson D. Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study. JMIR Formative Research 2024;8:e55614 View
  36. Miller S, Yang X, Qiao S. Longitudinal Impacts of Medicaid Expansion and Social Determinants of Health on PrEP Prevalence and PrEP-to-Need Ratio (PNR). AIDS Education and Prevention 2024;36(5):324 View
  37. Glick J, Nestadt D, Sanchez T, Li K, Hannah M, Rawlings M, Rinehart A, Sarkar S, Vannappagari V. Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP. Journal of the International Association of Providers of AIDS Care (JIAPAC) 2024;23 View

Books/Policy Documents

  1. Wilton L. HIV in US Communities of Color. View
  2. Ojikutu B, Stone V. HIV in US Communities of Color. View
  3. Duncan D, Kim B, Al-Ajlouni Y, Callander D. HIV in US Communities of Color. View